Moreover, in line with a previous study3, our results demonstrated that the cardiac biomarkers were highly related to lymphocyte count and CRP, suggesting that cardiac damage of COVID-19 was related to viral response and hyperinflammation. The gene discussed is CRP; the disease is COVID-19.